drugset / Trial / NCT05511714

Expanded Access [11C] Methionine PET Imaging

NCT05511714 ↗

Expanded access Available St. Jude Children's Research Hospital

Summary

The participants are being asked to get this PET scan because the participants have or may have cancer in the central nervous system (head, neck, or spine), and the investigator and the patient's physician thinks that this scan may provide useful information for the participant's treatment. Primary Objective To provide expanded access to L-\[11C\]methionine as a positron-emitting tracer in children and young adults for the positron emission tomography (PET) imaging of neoplasms of the central nervous system (CNS) and head and neck to guide therapeutic management of disease.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject L-(11C) methionine Diagnostic / imaging agent 20 unknown Intravenous